The U.S. Ketamine Clinic industry is growing fast.
This is because more people are looking for new ways to treat mental health problems. It’s already a $3.1B industry, but it’s expected to more than double over the next five years.
Read more
This ketamine trial for resistant depression shows positive results.
The study is the largest to date comparing generic ketamine with placebo in treating severe depression.
Read more
This article from The Guardian states: The ketamine industry, like the wide psychedelic industry, is experiencing growing pains.
One of the largest startup clinic chains offering ketamine treatment has just gone bust, another is in dire straits, and others face uncertainty.
Why are so many ketamine clinics struggling, even as demand is increasing?
Read more